Gilead Sciences, Inc.
CRYSTALLINE FORMS OF TENOFOVIR ALAFENAMIDE
Last updated:
Abstract:
The present invention relates to novel crystalline forms of salts and/or co-crystals of tenofovir alafenamide, the pharmaceutical formulations, and the therapeutic uses thereof in treating viral infections.
Status:
Application
Type:
Utility
Filling date:
21 Mar 2019
Issue date:
1 Aug 2019